2003 Quarterly Earnings Reports
Combichem and Services Sector Companies
Updated 11/10/04
Current publicly reported financial results (in $millions) for combinatorial chemistry-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Accelrys (ACCL) | $19.1 | ($3.8) | $17.7 | ($2.1) | $36.8 | ($5.9) | ||||
| Albany Molecular (ARMI) | $44.9 | $4.1 | $54.0 | $8.3 | $45.4 | $8.2 | $39.1 | $10.5 | $196.4 | $31.2 |
| Arena Pharmaceuticals (ARNA) | $5.4 | ($8.8) | $3.0 | ($11.8) | $2.9 | ($11.9) | $1.6 | ($14.7) | $12.9 | ($47.2) |
| Argonaut Technologies (AGNT) | $6.3 | ($2.5) | $6.9 | ($1.9) | $5.2 | ($3.1) | $6.2 | ($0.7) | $24.6 | ($8.2) |
| ArQule, Inc. (ARQL) | $15.7 | ($0.8) | $15.5 | $1.0 | $16.0 | ($29.9) | $18.4 | ($5.1) | $65.5 | ($34.8) |
| CompuGen (CGEN) | $2.6 | ($2.3) | $2.9 | ($2.4) | $2.0 | ($3.2) | $1.4 | ($3.5) | $8.9 | ($11.4) |
| Lion Bioscience (LEON), in Euros | 9.0 | (18.5) | 5.6 | (4.4) | 5.0 | (6.5) | 5.8 | (6.3) | 25.4 | (35.7) |
| Orchid Bioscience (ORCH) | $12.7 | ($4.3) | $12.4 | ($10.5) | $11.8 | ($5.0) | $13.7 | ($6.0) | $50.6 | ($25.8) |
| Pharmacopeia Drug Discovery(PCOP) | $7.5 | ($0.9) | $7.0 | ($0.7) | $7.4 | ($0.4) | $22.0 | ($2.0) | ||
| Pharmacopeia (PCOP) | $24.7 | ($5.5) | $26.1 | ($3.8) | $25.1 | ($2.1) | $39.1 | $7.9 | $115.0 | ($3.5) |
| Repligen (RGEN) | $2.1 | ($1.7) | $2.1 | ($2.0) | $1.4 | ($2.1) | $1.3 | ($2.1) | $6.8 | ($8.0) |
| Tripos, Inc. (TRPS) | $13.7 | $0.4 | $14.0 | $1.2 | $13.1 | $1.0 | $12.6 | ($452.0) | $53.4 | $2.1 |
| Totals for Results in USD | $135.5 | ($22.3) | $143.8 | ($22.6) | $130.3 | ($48.5) | $133.4 | ($465.7) | $556.0 | ($107.6) |
